Research at the University of Cincinnati (UC) is shedding light on how spinal cord neural pathways impact major depressive disorder (MDD). Francisco Romo-Nava, MD, PhD, presented findings at the International Society for Bipolar Disorders and published a review in the journal Discover Mental Health, indicating that spinal interoceptive pathways (SIP) could be viable therapeutic targets for mood disorders.
Read More
Romo-Nava's work centers on the communication between the brain and body in relation to psychiatric disorders. He argues that this connection plays a critical role in such conditions. "Emerging evidence suggests that many symptoms of mood disorders, eating disorders, and anxiety disorders are tied to dysregulation in brain-body interactions," he said. SIPs serve as conduits for neurons to relay information to the brain, which processes these signals. Romo-Nava posits that overload in this pathway could lead to depression, analogous to a traffic jam.
To validate this hypothesis, the research team utilized EEG data to track laser stimulation applied to participants’ feet, confirming that the signal was effectively transmitted along the SIPs to the brain.
Since 2020, Romo-Nava and his colleagues have been testing a patented noninvasive spinal cord electrical stimulation method aimed at alleviating congestion in the SIPs to treat mood disorders. Initial results indicate that this approach is both manageable and tolerable for reducing depressive symptoms, though the underlying mechanisms are still being explored.
The researchers sought to enhance their understanding of the electrical stimulation's effects on SIPs by observing brain wave responses to laser stimulation. Their NIMH-funded study revealed a connection between these laser-evoked potentials and depressive syndromes. Their findings highlight the significance of SIPs in regulating various bodily states, such as sleep, metabolism, and reproductive behavior, with disturbances in these pathways leading to greater physiological impacts.
"Understanding the functioning of spinal interoceptive pathways can provide insights into major depressive disorder and potentially other psychiatric conditions," Romo-Nava noted.
Looking ahead, the team aims to recruit more participants for a double-blinded randomized controlled trial to further examine the effects of electrical stimulation on SIPs. They also plan to develop specific markers to quantify this intervention.
Romo-Nava emphasized the importance of a meticulous scientific approach in their research, noting his pride in the work completed over nearly a decade. "We need to enhance our understanding of depressive syndromes to offer better therapeutic options for patients suffering from depression. While we remain optimistic about our findings, we approach our work with caution, and results will shape our future actions."
Spinal interoceptive pathways are vital neural pathways that transmit signals regarding internal bodily states, such as pain and temperature, to the brain, which uses this information to regulate essential functions including sleep and mood. Romo-Nava's research suggests that when SIPs become overloaded, it may lead to symptoms of depression, positioning them as key targets for new therapeutic strategies.